China National Accord Medicines Corp Ltd (200028) - Total Assets

Latest as of September 2025: HK$50.56 Billion HKD

Based on the latest financial reports, China National Accord Medicines Corp Ltd (200028) holds total assets worth HK$50.56 Billion HKD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

China National Accord Medicines Corp Ltd - Total Assets Trend (1992–2025)

This chart illustrates how China National Accord Medicines Corp Ltd's total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.

China National Accord Medicines Corp Ltd - Asset Composition Analysis

Current Asset Composition (December 2025)

China National Accord Medicines Corp Ltd's total assets of HK$50.56 Billion consist of 81.9% current assets and 18.1% non-current assets.

Asset Category Amount (HKD) % of Total Assets
Cash & Equivalents HK$0.00 15.9%
Accounts Receivable HK$21.54 Billion 43.9%
Inventory HK$8.12 Billion 16.5%
Property, Plant & Equipment HK$0.00 0.0%
Intangible Assets HK$406.69 Million 0.8%
Goodwill HK$1.60 Billion 3.3%

Asset Composition Trend (1992–2025)

This chart illustrates how China National Accord Medicines Corp Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: China National Accord Medicines Corp Ltd's current assets represent 81.9% of total assets in 2025, an increase from 45.4% in 1992.
  • Cash Position: Cash and equivalents constituted 15.9% of total assets in 2025, down from 33.9% in 1992.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, a decrease from 21.0% in 1992.
  • Asset Diversification: The largest asset category is accounts receivable at 43.9% of total assets.

China National Accord Medicines Corp Ltd Competitors by Total Assets

Key competitors of China National Accord Medicines Corp Ltd based on total assets are shown below.

Company Country Total Assets
C.Q. Pharmaceutical Holding Co Ltd
SHE:000950
China CN¥67.71 Billion
Shenzhen Glory Medical Co Ltd
SHE:002551
China CN¥3.56 Billion
Shandong Realcan Pharmaceutical Co Ltd
SHE:002589
China CN¥15.33 Billion
Hanmi Science
KO:008930
Korea ₩1.49 Trillion
BCM Alliance Bhd
KLSE:0187
Malaysia RM147.86 Million
Qingdao Baheal Medical INC.
SHE:301015
China CN¥7.59 Billion
Excelsior Medical Co Ltd
TW:4104
Taiwan NT$18.80 Billion
CHC Healthcare Group
TW:4164
Taiwan NT$14.83 Billion

China National Accord Medicines Corp Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.50 1.45 1.44
Quick Ratio 1.20 1.15 1.13
Cash Ratio 0.00 0.00 0.00
Working Capital HK$13.71 Billion HK$12.59 Billion HK$9.00 Billion

China National Accord Medicines Corp Ltd - Advanced Valuation Insights

This section examines the relationship between China National Accord Medicines Corp Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 0.37
Latest Market Cap to Assets Ratio 0.00
Asset Growth Rate (YoY) 3.2%
Total Assets HK$49.10 Billion
Market Capitalization $126.42 Million USD

Valuation Analysis

Below Book Valuation: The market values China National Accord Medicines Corp Ltd's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: China National Accord Medicines Corp Ltd's assets grew by 3.2% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for China National Accord Medicines Corp Ltd (1992–2025)

The table below shows the annual total assets of China National Accord Medicines Corp Ltd from 1992 to 2025.

Year Total Assets Change
2025-12-31 HK$49.10 Billion +3.24%
2024-12-31 HK$47.56 Billion -0.03%
2023-12-31 HK$47.57 Billion +11.63%
2022-12-31 HK$42.62 Billion -0.39%
2021-12-31 HK$42.78 Billion +8.05%
2020-12-31 HK$39.59 Billion +18.12%
2019-12-31 HK$33.52 Billion +15.87%
2018-12-31 HK$28.93 Billion +29.48%
2017-12-31 HK$22.34 Billion +4.84%
2016-12-31 HK$21.31 Billion +61.24%
2015-12-31 HK$13.22 Billion +3.04%
2014-12-31 HK$12.83 Billion +16.02%
2013-12-31 HK$11.06 Billion +18.96%
2012-12-31 HK$9.30 Billion +21.26%
2011-12-31 HK$7.67 Billion +21.55%
2010-12-31 HK$6.31 Billion +20.51%
2009-12-31 HK$5.23 Billion +42.06%
2008-12-31 HK$3.68 Billion +26.77%
2007-12-31 HK$2.91 Billion +8.47%
2006-12-31 HK$2.68 Billion +149.82%
2005-12-31 HK$1.07 Billion +26.74%
2004-12-31 HK$846.19 Million -16.08%
2003-12-31 HK$1.01 Billion -4.21%
2002-12-31 HK$1.05 Billion -5.86%
2001-12-31 HK$1.12 Billion +127.79%
2000-12-31 HK$490.89 Million -8.92%
1999-12-31 HK$538.95 Million -4.16%
1998-12-31 HK$562.36 Million +13.42%
1997-12-31 HK$495.82 Million +11.02%
1996-12-31 HK$446.60 Million +17.46%
1995-12-31 HK$380.21 Million +0.12%
1994-12-31 HK$379.76 Million -1.12%
1993-12-31 HK$384.07 Million +103.29%
1992-12-31 HK$188.93 Million --

About China National Accord Medicines Corp Ltd

SHE:200028 China Medical Distribution
Market Cap
$126.42 Million
HK$990.36 Million HKD
Market Cap Rank
#19891 Global
#4685 in China
Share Price
HK$13.88
Change (1 day)
-0.86%
52-Week Range
HK$10.98 - HK$14.07
All Time High
HK$1125.97
About

China National Accord Medicines Corporation Ltd. engages in the retail and distribution of pharmaceutical products in China and internationally. The company offers new and special drugs and medications for chronic diseases. It also provides traditional Chinese medicine, Western medicine, rehabilitation therapy, and various medical-related resources, as well as chemical drugs, OTC drugs, and healt… Read more